Dietary menhaden, seal, and corn oils differentially affect lipid and ex vivo eicosanoid and thiobarbituric acid-reactive substances generation in the guinea pig.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Wiley Subscription Services, Inc Country of Publication: United States NLM ID: 0060450 Publication Model: Print Cited Medium: Print ISSN: 0024-4201 (Print) Linking ISSN: 00244201 NLM ISO Abbreviation: Lipids Subsets: MEDLINE
    • Publication Information:
      Publication: 2018- : Hoboken, NJ : Wiley Subscription Services, Inc.
      Original Publication: Chicago, American Oil Chemists' Society.
    • Subject Terms:
    • Abstract:
      This investigation was carried out to characterize the effects of specific dietary marine oils on tissue and plasma fatty acids and their capacity to generate metabolites (prostanoids, lipid peroxides). Young male guinea pigs were fed nonpurified diet (NP), or NP supplemented (10%, w/w) with menhaden fish oil (MO), harp seal oil (SLO), or corn oil (CO, control diet) for 23 to 28 d. Only the plasma showed significant n-3 polyunsaturated fatty acid (PUFA)-induced reductions in triacylglycerol (TAG) or total cholesterol concentration. Proportions of total n-3 PUFA in organs and plasma were elevated significantly in both MO and SLO dietary groups (relative to CO), and in all TAG fractions levels were significantly higher in MO- than SLO-fed animals. The two marine oil groups differed in their patterns of incorporation of eicosapentaenoic acid (EPA). In guinea pigs fed MO, the highest levels of EPA were in the plasma TAG, whereas in SLO-fed animals, maximal incorporation of EPA was in the heart polar lipids (PL). In both marine oil groups, the greatest increases in both docosahexaenoic acid (22:6n-3, DHA) and docosapentaenoic acid (22:5n-3, DPA), relative to the CO group, were in plasma TAG, although the highest proportions of DHA and DPA were in liver PL and heart TAG, respectively. In comparing the MO and SLO groups, the greatest difference in levels of DHA was in heart TAG (MO > SLO, P < 0.005), and in levels of DPA was in heart PL (SLO > MO, P < 0.0001). The only significant reduction in proportions of the major n-6 PUFA, arachidonic acid (AA), was in the heart PL of the SLO group (SLO > MO = CO, P < 0.005). Marine oil feeding altered ex vivo generation of several prostanoid metabolites of AA, significantly decreasing thromboxane A2 synthesis in homogenates of hearts and livers of guinea pigs fed MO and SLO, respectively (P < 0.04 for both, relative to CO). Lipid peroxides were elevated to similar levels in MO- and SLO-fed animals in plasma, liver, and adipose tissue, but not in heart preparations. This study has shown that guinea pigs respond to dietary marine oils with increased organ and plasma n-3 PUFA, and changes in potential synthesis of metabolites. They also appear to respond to n-3 PUFA-enriched diets in a manner that is different from that of rats.
    • References:
      Lipids. 1996 Mar;31(3):341-4. (PMID: 8900465)
      Lipids. 1996 Mar;31 Suppl:S45-9. (PMID: 8729093)
      Lipids. 1998 Apr;33(4):427-36. (PMID: 9590631)
      Br J Clin Pharmacol. 1997 Oct;44(4):307-17. (PMID: 9354304)
      Br J Nutr. 1997 Jul;78 Suppl 1:S5-13. (PMID: 9292771)
      Biochim Biophys Acta. 1984 Sep 12;795(2):196-207. (PMID: 6548159)
      Am J Clin Nutr. 1986 Apr;43(4):566-98. (PMID: 3515901)
      Lipids. 1998 Sep;33(9):897-904. (PMID: 9778137)
      Am J Physiol. 1995 Jan;268(1 Pt 2):H308-15. (PMID: 7840277)
      Circulation. 1996 Oct 1;94(7):1774-80. (PMID: 8840874)
      J Nutr. 1997 Mar;127(3):383-93. (PMID: 9082021)
      Atherosclerosis. 1988 Mar;70(1-2):171-3. (PMID: 2833284)
      J Lipid Res. 1992 Jan;33(1):97-109. (PMID: 1313073)
      J Lipid Res. 1989 Jun;30(6):785-807. (PMID: 2677200)
      Lipids. 1995 Dec;30(12):1111-8. (PMID: 8614301)
      Prog Lipid Res. 1996 Dec;35(4):409-57. (PMID: 9246358)
      Can J Physiol Pharmacol. 1997 Aug;75(8):945-51. (PMID: 9360007)
      J Nutr. 1986 Apr;116(4):514-23. (PMID: 3958799)
      Prostaglandins. 1997 Aug;54(2):511-30. (PMID: 9380795)
      Biochem J. 1988 Jan 15;249(2):351-6. (PMID: 3342019)
      Clin Chem. 1987 Feb;33(2 Pt 1):214-20. (PMID: 3802504)
      J Nutr. 1994 Mar;124(3):331-9. (PMID: 8120651)
      Mol Cell Biochem. 1997 Dec;177(1-2):257-69. (PMID: 9450671)
      Biochim Biophys Acta. 1984 Apr 18;793(2):221-31. (PMID: 6712967)
      Biochim Biophys Acta. 1996 Mar 1;1305(3):163-71. (PMID: 8597602)
      Lipids. 1995 Dec;30(12 ):1151-6. (PMID: 8614306)
      Am J Clin Nutr. 1996 Jun;63(6):985S-990S. (PMID: 8644698)
      J Nutr. 1995 Sep;125(9):2286-93. (PMID: 7666244)
      Acta Med Scand. 1980;208(5):401-6. (PMID: 7457208)
      Mol Cell Biochem. 1992 Oct 21;116(1-2):19-25. (PMID: 1480148)
      Can J Biochem Physiol. 1959 Aug;37(8):911-7. (PMID: 13671378)
      Lipids. 1996 Mar;31(3):243-52. (PMID: 8900453)
      J Clin Invest. 1985 Oct;76(4):1626-31. (PMID: 2997286)
      Am J Physiol. 1991 Feb;260(2 Pt 2):H379-85. (PMID: 1899979)
      Pediatr Res. 1997 Jan;41(1):1-10. (PMID: 8979282)
      Development. 1990 Feb;108(2):331-6. (PMID: 2351072)
      Biochem Pharmacol. 1991 Oct 9;42(9):1711-5. (PMID: 1930297)
      Lipids. 1997 Jul;32(7):697-705. (PMID: 9252957)
      Prostaglandins Leukot Essent Fatty Acids. 1996 May;54(5):319-25. (PMID: 8832760)
      J Intern Med Suppl. 1989;731:61-8. (PMID: 2650699)
      J Nutr. 1992 Oct;122(10):2019-29. (PMID: 1527642)
      J Am Coll Nutr. 1990 Aug;9(4):344-51. (PMID: 2212393)
      J Nutr. 1991 Sep;121(9):1331-40. (PMID: 1880611)
    • Accession Number:
      0 (Eicosanoids)
      0 (Fatty Acids, Omega-3)
      0 (Fish Oils)
      0 (Lipids)
      0 (Plant Oils)
      0 (Thiobarbituric Acid Reactive Substances)
      1D8HWC57D0 (Menhaden oil)
    • Publication Date:
      Date Created: 19990402 Date Completed: 19990610 Latest Revision: 20190814
    • Publication Date:
      20231215
    • Accession Number:
      10.1007/s11745-999-0344-1
    • Accession Number:
      10102237